Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after <scp>COVID</scp>‐19 vaccine
This study generated evidence to guide anticoagulation in patients with VTE after vaccination for COVID-19. We provided data on the low recurrence rate after cessation of anticoagulant therapy and the findings for this study offer timely insights into the management of a potentially vaccine-related adverse event.
Authors
- Juan J. López-Núñez
- Pablo Demelo‐Rodríguez (ORCID: https://orcid.org/0000-0002-3096-4711)
- Joaquín Alfonso Megido
- Luis Jara‐Palomares (ORCID: https://orcid.org/0000-0002-4125-3376)
- Isabelle Mahé (ORCID: https://orcid.org/0000-0003-1760-7880)
- Alfonso Muriel (ORCID: https://orcid.org/0000-0002-4805-4011)
- Behnood Bikdeli (ORCID: https://orcid.org/0000-0003-1428-879X)
- Begoña Fernández Jiménez (ORCID: https://orcid.org/0000-0001-5085-7967)
- David Jiménez (ORCID: https://orcid.org/0000-0002-4571-7721)
- Manuel Monreal
Institutions
- Universitat Autònoma de Barcelona (ES)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Inserm (FR)
- Universidad de Alcalá (ES)
- Université Paris Cité (FR)
- Instituto de Salud Carlos III (ES)
- Hospital General Universitario Gregorio Marañón (ES)
- Hôpital Louis-Mourier (FR)
- H.B. Fuller (United States) (US)
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (ES)
- Cardiovascular Research Foundation (US)
- Hospital Valle del Nalón (ES)
- Hospital Universitario Virgen del Rocío (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
- Hospital Universitario de Móstoles (ES)
- Universidad Católica de Murcia (ES)
Publication Details
- Journal
- European Journal of Clinical Investigation
- Published
- 2024-09-04
- DOI
- https://doi.org/10.1111/eci.14310
- Citations
- 2
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.10
Funders
- Sanofi
- Sanofi España